| 发明名称 |
ANTI-TUMOUR IMMUNE RESPONSES TO MODIFIED SELF-EPITOPES |
| 摘要 |
The present invention relates to modified citrullinated enolase peptides that can be used as targets for cancer immunotherapy. These peptides can be used as vaccines or as targets for monoclonal antibody (mAb) therapy. Such vaccines or mAbs may be used in the treatment of cancer. |
| 申请公布号 |
WO2017013425(A1) |
申请公布日期 |
2017.01.26 |
| 申请号 |
WO2016GB52181 |
申请日期 |
2016.07.19 |
| 申请人 |
SCANCELL LIMITED |
发明人 |
DURRANT, Linda Gillian;BRENTVILLE, Victoria Anne;METHERINGHAM, Rachel Louise |
| 分类号 |
C07K7/08;A61K38/10;C07K16/18;C12N9/88 |
主分类号 |
C07K7/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
